These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 8285609

  • 1. Double-blind, comparative study of rufloxacin once daily versus amoxicillin three times a day in treatment of outpatients with exacerbations of chronic bronchitis.
    Klietmann W, Cesana M, Rondel RK, Focht J.
    Antimicrob Agents Chemother; 1993 Nov; 37(11):2298-306. PubMed ID: 8285609
    [Abstract] [Full Text] [Related]

  • 2. Randomized, double-blind study of grepafloxacin versus amoxycillin in patients with acute bacterial exacerbations of chronic bronchitis.
    Langan CE, Cranfield R, Breisch S, Pettit R.
    J Antimicrob Chemother; 1997 Dec; 40 Suppl A():63-72. PubMed ID: 9484875
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of a 10-day course of 400 or 600 milligrams of grepafloxacin once daily for treatment of acute bacterial exacerbations of chronic bronchitis: comparison with a 10-day course of 500 milligrams of ciprofloxacin twice daily.
    Chodosh S, Lakshminarayan S, Swarz H, Breisch S.
    Antimicrob Agents Chemother; 1998 Jan; 42(1):114-20. PubMed ID: 9449270
    [Abstract] [Full Text] [Related]

  • 4. Sparfloxacin vs ofloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis: a multicenter, double-blind, randomized, comparative study. Sparfloxacin Multicenter ABECB Study Group.
    DeAbate CA, Henry D, Bensch G, Jubran A, Chodosh S, Harper L, Tipping D, Talbot GH.
    Chest; 1998 Jul; 114(1):120-30. PubMed ID: 9674458
    [Abstract] [Full Text] [Related]

  • 5. Treatment of acute exacerbations of chronic bronchitis: comparison of trovafloxacin and amoxicillin in a multicentre, double-blind, double-dummy study. Trovafloxacin Bronchitis Study Group.
    O'Doherty B, Daniel R.
    Eur J Clin Microbiol Infect Dis; 1998 Jun; 17(6):441-6. PubMed ID: 9758290
    [Abstract] [Full Text] [Related]

  • 6. Gemifloxacin versus amoxicillin/clavulanate in the treatment of acute exacerbations of chronic bronchitis. The 070 Clinical Study group.
    File T, Schlemmer B, Garau J, Lode H, Lynch S, Young C.
    J Chemother; 2000 Aug; 12(4):314-25. PubMed ID: 10949981
    [Abstract] [Full Text] [Related]

  • 7. Safety and efficacy of lomefloxacin versus cefaclor in the treatment of acute exacerbations of chronic bronchitis.
    Gotfried MH, Ellison WT.
    Am J Med; 1992 Apr 06; 92(4A):108S-113S. PubMed ID: 1316059
    [Abstract] [Full Text] [Related]

  • 8. Effectiveness of short-course therapy (5 days) with grepafloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis.
    DeAbate CA, Bettis R, Munk ZM, Fleming H, Munn NJ, Riffer E, Bagby B, Giguere G, Collins JJ.
    Clin Ther; 1999 Jan 06; 21(1):172-88. PubMed ID: 10090434
    [Abstract] [Full Text] [Related]

  • 9. A double-blind study of two dosage regimens of lomefloxacin in bacteriologically proven exacerbations of chronic bronchitis of gram-negative etiology.
    Kemper P, Köhler D.
    Am J Med; 1992 Apr 06; 92(4A):98S-102S. PubMed ID: 1316079
    [Abstract] [Full Text] [Related]

  • 10. Rufloxacin once daily versus ciprofloxacin twice daily in the treatment of patients with acute uncomplicated pyelonephritis.
    Bach D, van den Berg-Segers A, Hübner A, van Breukelen G, Cesana M, Plétan Y.
    J Urol; 1995 Jul 06; 154(1):19-24. PubMed ID: 7776420
    [Abstract] [Full Text] [Related]

  • 11. Comparative safety and efficacy of sparfloxacin in the treatment of acute exacerbations of chronic obstructive pulmonary disease: a double-blind, randomised, parallel, multicentre study.
    Allegra L, Konietzko N, Leophonte P, Hosie J, Pauwels R, Guyen JN, Petitpretz P.
    J Antimicrob Chemother; 1996 May 06; 37 Suppl A():93-104. PubMed ID: 8737129
    [Abstract] [Full Text] [Related]

  • 12. Lomefloxacin versus amoxicillin in the treatment of acute exacerbations of chronic bronchitis: an Italian multicenter study.
    Grassi C, Albera C, Pozzi E.
    Am J Med; 1992 Apr 06; 92(4A):103S-107S. PubMed ID: 1316058
    [Abstract] [Full Text] [Related]

  • 13. Rufloxacin once daily in acute exacerbations of chronic bronchitis.
    Dirksen M, Focht J, Boerema J.
    Infection; 1991 Apr 06; 19(4):297-300. PubMed ID: 1917050
    [Abstract] [Full Text] [Related]

  • 14. Effectiveness of short-course therapy (5 days) with cefuroxime axetil in treatment of secondary bacterial infections of acute bronchitis.
    Henry D, Ruoff GE, Rhudy J, Puopolo A, Drehobl M, Schoenberger J, Giguere G, Collins JJ.
    Antimicrob Agents Chemother; 1995 Nov 06; 39(11):2528-34. PubMed ID: 8585739
    [Abstract] [Full Text] [Related]

  • 15. Randomized, double-blind, comparative study of grepafloxacin and amoxycillin in the treatment of patients with community-acquired pneumonia.
    O'Doherty B, Dutchman DA, Pettit R, Maroli A.
    J Antimicrob Chemother; 1997 Dec 06; 40 Suppl A():73-81. PubMed ID: 9484876
    [Abstract] [Full Text] [Related]

  • 16. Clinical comparison of cefuroxime axetil and amoxicillin/clavulanate in the treatment of patients with secondary bacterial infections of acute bronchitis.
    Henry D, Ruoff GE, Rhudy J, Puopolo A, Drehobl M, Schoenberger J, Giguere G, Collins JJ.
    Clin Ther; 1995 Dec 06; 17(5):861-74. PubMed ID: 8595638
    [Abstract] [Full Text] [Related]

  • 17. Double-blind randomized study comparing the efficacies and safeties of a short (3-day) course of azithromycin and a 5-day course of amoxicillin in patients with acute exacerbations of chronic bronchitis.
    Mertens JC, van Barneveld PW, Asin HR, Ligtvoet E, Visser MR, Branger T, Hoepelman AI.
    Antimicrob Agents Chemother; 1992 Jul 06; 36(7):1456-9. PubMed ID: 1324645
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of fleroxacin versus amoxicillin in acute exacerbations of chronic bronchitis.
    Chodosh S.
    Am J Med; 1993 Mar 22; 94(3A):131S-135S. PubMed ID: 8452169
    [Abstract] [Full Text] [Related]

  • 19. Randomized, double-blind study of short-course (5 day) grepafloxacin versus 10 day clarithromycin in patients with acute bacterial exacerbations of chronic bronchitis.
    Langan CE, Zuck P, Vogel F, McIvor A, Peirzchala W, Smakal M, Staley H, Marr C.
    J Antimicrob Chemother; 1999 Oct 22; 44(4):515-23. PubMed ID: 10588313
    [Abstract] [Full Text] [Related]

  • 20. Once-daily sparfloxacin versus high-dosage amoxicillin in the treatment of community-acquired, suspected pneumococcal pneumonia in adults. Sparfloxacin European Study Group.
    Aubier M, Verster R, Regamey C, Geslin P, Vercken JB.
    Clin Infect Dis; 1998 Jun 22; 26(6):1312-20. PubMed ID: 9636854
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.